Article: New strategy for developing 'next-generation' malaria vaccines.

Byline: ANI

Washington, Nov 3 (ANI): Experts have suggested a novel strategy for developing 'next-generation' malaria vaccines that will help targeting the long-term goal of eliminating and eradicating the deadly mosquito-borne disease.

While trials are underway testing the efficacy if GlaxoSmithKline Biologicals' (GSK Bio) RTS, S malaria vaccine, experts linked to PATH Malaria Vaccine Initiative (MVI) have suggested new approaches.

While most malaria vaccine candidates use one or more components of the malaria parasite to elicit an immune response, another approach uses a weakened form of the whole parasite.

MVI is working with ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!